|
Status |
Public on Mar 21, 2019 |
Title |
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Using genome-wide sequencing approaches we viewed the contributions of Toll-like receptor 7 (TLR7) and type I interferon (IFN-I) in the regulation of coding and noncoding RNA expression in CAL-1 pDC treated with R848 or IFNβ. Functional enrichment analysis revealed both the unique and synergistic roles of TLR7 and IFN-I signaling in the orchestration of pDC function.
|
|
|
Overall design |
Total RNA-seq profiling was performed on CAL-1 cells (1 million cells/mL) were cultured in 0.1% FBS CAL-1 media in triplicate in a 12- well tissue culture plate for 6 hours prior to stimulation with 1,000 U/mL recombinant human IFN-β (PBL Interferon Source) or 1ug/mL R848 (Invitrogen) or 1ug/mL R848 (Invitrogen) + 1ug/mL recombinant vaccinia virus B18R protein (Thermo Fisher Scientific) or mock stimulation. Total RNA was harvested 12 hours post stimulation
|
|
|
Contributor(s) |
Joslyn R, Forero A, Ozarkar S, Lee CH, So L, Green R, Savan R |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Jul 16, 2018 |
Last update date |
Mar 26, 2019 |
Contact name |
Michael Gale, Jr |
E-mail(s) |
uw_galelab_geo@uw.edu
|
Organization name |
University of Washington
|
Department |
Immunology
|
Street address |
750 Republican St. E360, Box 358059
|
City |
Seattle |
State/province |
Washington |
ZIP/Postal code |
98109 |
Country |
USA |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (12)
|
GSM3271607 |
CAL-1 control mock treated at 12hr rep 1 |
GSM3271608 |
CAL-1 control mock treated at 12hr rep 2 |
GSM3271609 |
CAL-1 control mock treated at 12hr rep 3 |
GSM3271610 |
CAL-1 control IFN Beta treated at 12hr rep 1 |
GSM3271611 |
CAL-1 control IFN Beta treated at 12hr rep 2 |
GSM3271612 |
CAL-1 control IFN Beta treated at 12hr rep 3 |
GSM3271613 |
CAL-1 control IFN Lambda treated at 12hr rep 1 |
GSM3271614 |
CAL-1 control IFN Lambda treated at 12hr rep 2 |
GSM3271615 |
CAL-1 control IFN Lambda treated at 12hr rep 3 |
GSM3271616 |
CAL-1 control IFN Beta treated at 12hr rep 1 with R848 + recombinant vaccinia virus B18R protein |
GSM3271617 |
CAL-1 control IFN Beta treated at 12hr rep 2 with R848 + recombinant vaccinia virus B18R protein |
GSM3271618 |
CAL-1 control IFN Beta treated at 12hr rep 3 with R848 + recombinant vaccinia virus B18R protein |
|
Relations |
BioProject |
PRJNA481248 |
SRA |
SRP153809 |